By THÉRÈSE MARGOLIS     Ever since 1987, when the Canadian dermatologist Alastair Carruthers first stumbled upon the discovery that botulinum toxin, a medication used in the treatment of Parkinson’s disease and other neurological conditions, had a secondary effect of diminishing the appearance of facial wrinkles, women around the globe have been lining up by the thousands for Botox treatments to soften